12:00 AM
 | 
Apr 12, 2010
 |  BC Week In Review  |  Company News  |  Deals

Crucell, GlaxoSmithKline deal

Crucell and GSK partnered to develop a second-generation malaria vaccine. Crucell will contribute its AdVac Ad35-CS recombinant malaria vaccine, and GSK will contribute its...

Read the full 120 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >